APO 866,
APO-866,
APO866,
FK 866,
FK-866,
FK866 cpd,
N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide,
658084-64-1,
Daporinad,
FK866,
FK-866,
APO-866,
APO866,
APO 866,
UNII-V71TF6V9M7,
Daporinad [INN],
FK 866,
(E)-N-(4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL)-3-(PYRIDIN-3-YL)ACRYLAMIDE,
V71TF6V9M7,
Daporinad (FK866, APO866),
FK 866 hydrochloride,
FK866 (APO866),
(2E)-N-(4-(1-Benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)prop-2-enamide,
(2E)-N-[4-(1-Benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide,
(2e)-N-{4-[1-(Benzenecarbonyl)piperidin-4-Yl]butyl}-3-(Pyridin-3-Yl)prop-2-Enamide,
2gvj,
AC1OCAEU,
4o1b,
4o1d,
N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide,
apo866-fk866,
FK866 hydrochloride hydrate,
CHEMBL566757,
Daporinad(FK866,APO866),
GTPL7745,
BDBM81395,
CHEBI:94671,
EX-A430,
2g97,
KPBNHDGDUADAGP-VAWYXSNFSA-N,
BCP01909,
ZINC3828115,
2411AH,
ABP000267,
FD5006,
FK866/,
MFCD10565943,
s2799,
AKOS015994576,
API0004712,
BCP9000687,
CCG-208012,
DB12731,
ES-0047,
SB19583,
BC251105,
QC-11600,
RT-012720,
W-5446,
BRD-K58550667-001-01-2,
(E)-N-[4-(1-Benzoyl-piperidin-4-yl)-butyl]-3-pyridin-3-yl-acrylamide,
(E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide,
(E)-N-[4-[1-(benzoyl)piperidin-4-yl]butyl]-3-pyridin-3-ylprop-2-enamide,
n-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2e-propenamide,
(E)-N-[4-[1-(Benzoyl)Piperidin-4-yl]Butyl]-3-Pyridin-3-yl Prop-2-enamide,
FK866 cpd,
D0H9SX,
C24H29N3O2,
WK-175,
CID6914657,
A8631,
A11279,
C480543,
658084-64-1 (or 201034-75-5),
(E)-N-[4-(1-benzoyl-4-piperidyl)butyl]-3-pyridin-3-yl-prop-2-enamide,
201034-75-5,
DGB,